Top compounds associated with response to FBXO31


Feature Type Standardized
Nominal ANOVA
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.062 0.08
mRNA Doxorubicin gCSI pan-cancer AAC -0.093 0.08
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.08
mRNA Erlotinib gCSI pan-cancer AAC -0.1 0.08
mRNA Ko-143 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA thapsigargin gCSI pan-cancer AAC -0.1 0.08
mRNA skepinone-L CTRPv2 pan-cancer AAC -0.09 0.08
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.09
mRNA Crizotinib gCSI pan-cancer AAC -0.099 0.09
mRNA IU1 CTRPv2 pan-cancer AAC 0.065 0.09
Download CSV